- Home
- MODV vs VRCA Comparison
MODV vs VRCA Comparison
Compare MODV & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MODV
- VRCA
- Stock Information
- Founded
- MODV 1996
- VRCA 2013
- Country
- MODV United States
- VRCA United States
- Employees
- MODV N/A
- VRCA N/A
- Industry
- MODV Transportation Services
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- MODV Consumer Discretionary
- VRCA Health Care
- Exchange
- MODV Nasdaq
- VRCA Nasdaq
- Market Cap
- MODV 81.8M
- VRCA 66.7M
- IPO Year
- MODV N/A
- VRCA 2018
- Fundamental
- Price
- MODV $5.05
- VRCA $0.74
- Analyst Decision
- MODV Buy
- VRCA Hold
- Analyst Count
- MODV 5
- VRCA 5
- Target Price
- MODV $18.20
- VRCA $6.00
- AVG Volume (30 Days)
- MODV 634.6K
- VRCA 220.3K
- Earning Date
- MODV 03-04-2025
- VRCA 03-03-2025
- Dividend Yield
- MODV N/A
- VRCA N/A
- EPS Growth
- MODV N/A
- VRCA N/A
- EPS
- MODV N/A
- VRCA N/A
- Revenue
- MODV $2,787,619,000.00
- VRCA $9,210,000.00
- Revenue This Year
- MODV $3.37
- VRCA $64.32
- Revenue Next Year
- MODV $2.71
- VRCA $73.76
- P/E Ratio
- MODV N/A
- VRCA N/A
- Revenue Growth
- MODV 3.16
- VRCA 187.45
- 52 Week Low
- MODV $3.64
- VRCA $0.61
- 52 Week High
- MODV $39.48
- VRCA $11.41
- Technical
- Relative Strength Index (RSI)
- MODV 38.32
- VRCA 55.52
- Support Level
- MODV $5.73
- VRCA $0.69
- Resistance Level
- MODV $6.09
- VRCA $0.78
- Average True Range (ATR)
- MODV 0.60
- VRCA 0.05
- MACD
- MODV 0.35
- VRCA 0.01
- Stochastic Oscillator
- MODV 54.23
- VRCA 73.07
About MODV ModivCare Inc.
ModivCare Inc is a technology-enabled healthcare services company that provides a suite of integrated supportive care solutions for payors and their members. The company is also a provider of non-emergency medical transportation, or NEMT, personal care, and remote patient monitoring, or RPM, solutions, which serve similar, highly vulnerable patient populations. Its operating segment includes NEMT, Personal Care, and Remote Patient Monitoring. The company generates maximum revenue from the NEMT segment.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.